can tirzepatide cause liver issues Dosing: Diabetes vs Weight Loss Metabolic Dysfunction–Associated Steatotic Liver Disease

That determination changed the regulatory landscape for compounded tirzepatide products

"The FDA's compounding program aims to protect patients from poor quality compounded drugs, while preserving access to lawfully marketed compounded drugs for patients." Compound versions of drugs -- made for individual patients using raw ingredients -- are not required to go through the FDA's rigorous approval process

Simple Peptide batch-specific COAs make this documentation straightforward

The cost of treatment can be a financial barrier for many who are interested in medical weight loss

A Cleveland Clinic study tracking 288 adults with overweight or obesity between January 2022 and December 2024 found that 61.0% of Medicare patients and 76.5% of Medicaid patients stopped treatment due to cost or insurance issues, compared to 43.0% of privately insured patients